CA-NETAPP,-INC.
20.10.2021 17:02:11 CEST | Business Wire | Press release
NetApp (NASDAQ: NTAP) a global, cloud-led, data-centric software company, today announced continued growth and momentum helping organizations unlock the best of cloud at less cost, through its collaboration with the world’s three largest public clouds.
NetApp’s expansion in the cloud has been driven by customers and supported by these partnerships, accelerating NetApp’s public cloud services’ customer and financial growth by bringing its leading CloudOps and ITOps solutions to existing and new addressable customers. Furthering its investment in the cloud, NetApp acquired Data Mechanics in early fiscal year (FY)’22, and this month announced the intent to acquire CloudCheckr to bolster the Spot by NetApp portfolio’s existing continuous cloud optimization capabilities.
This growth, driven by NetApp’s ONTAP data management software, which provides high-performance shared storage for file and block workloads, has propelled the native integration of NetApp’s cloud file services into each of the major public clouds.
“The three largest public clouds in the world are choosing NetApp, because customers are choosing ONTAP,” said Anthony Lye, Executive Vice President & General Manager, Public Cloud Services at NetApp. “Our strategy has positioned ONTAP as the native shared storage solution with rich data services inside the three public clouds. Now, our public cloud partners provide customers with the simplest path to the cloud and allow them to derive the most value from their data and applications.”
“The completeness of NetApp’s offering, combined with the ability to address a very broad set of storage use cases beyond cloud file storage, and the availability as a Tier 1 offering both on AWS and Azure, makes it a compelling choice,” said Enrico Signoretti, Senior Data Storage Analyst at GigaOm.1
Microsoft Azure
NetApp has partnered with Microsoft for nearly 30 years. In 2021 Microsoft recognized NetApp as the global Customer Experience Partner of the Year , and the U.S. SAP on Azure Partner of the Year . In the last 12 months, NetApp has more than tripled the number of co-sells offered on the Azure Marketplace, making it easy for Azure customers to consume NetApp’s leading cloud services.
Since its general availability in 2019, Azure NetApp Files (ANF), a fully managed, first-party service sold, billed, and supported by Microsoft in 35+ regions globally and is the first and only shared file service certified for use with SAP HANA. Recent innovations with Azure include the general availability of Azure Cross Region Replication, public preview of Azure NetApp Files Backup to preserve storage efficiencies, and of Spot PC for secure, optimized Azure Virtual Desktop-based Cloud PC environments.
“Alongside NetApp, we have worked with ANF customers to successfully migrate and run some of their largest and most important ONTAP production workloads, enabling the most demanding applications with performance and scale that meets or beats what they get on-premises,” said Jurgen Willis, Vice President, Product Management at Microsoft Azure Storage.
“With ANF, we get scalability and flexibility, which is important for businesses to run and have a faster time-to-market for their products,” said Lalit Patel, Chief Technology Officer, Enterprise Cloud Services at SAP. “We are able to deploy environments almost 30 to 40 percent faster and reduce the number of outages by 80 percent because of the stability that ANF provides.”
Google Cloud
NetApp and Google Cloud began collaborating in 2018, introduced NetApp Cloud Volumes Service (CVS) for Google Cloud in 2019, and launched NetApp Astra with support for Google Cloud in 2020. Earlier this month Google announced that NetApp would serve as the primary data and storage vendor for its new Google Distributed Cloud Hosted offering and introduced the integration of Google Cloud VMware Engine with NetApp Cloud Volumes Service support for VM datastores - a fully managed service that helps organizations meet their need for virtual workload storage and disaster recovery.
“Our partnership with NetApp continues to grow, rolling out new capabilities that will make it easier and more cost-effective to deliver enterprise workloads on Google Cloud and bringing customers even more flexibility across hybrid and cloud deployments,” said Bronwyn Hastings, Vice President Global Technology Partnerships at Google Cloud.
“With NetApp's deep integrations with Google Cloud, we're reaping all of the benefits of the cloud as a service, with configurations preset, elasticity built-in and disaster recovery capabilities in place within five minutes,” said Tom Gentry, Technologist at Gunpowder. “By making the technology challenges disappear for these studios, we're able to deliver the high performance our customers need anywhere in the world.”
Additionally, Spot by NetApp and Google Cloud have partnered to help companies take full advantage of the recently announced Google Spot VMs . With this, Google Cloud customers can continuously optimize performance, availability and cost with Spot by NetApp for cloud cost savings without the risk of service interruption.
Additional Resources
- Press Release: NetApp Expands Hybrid Cloud Solutions Portfolio to Unlock Best of Cloud at INSIGHT 2021 Digital
- Blog post: Ungated Innovation: Azure NetApp Files
- Blog post: NetApp INSIGHT ‘21 - Google Cloud Momentum
About NetApp
NetApp is a global cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter , LinkedIn , Facebook , and Instagram .
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
1 Source: GigaOm, Radar for Cloud File Systems, September 22, 2021
View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005583/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom